Estrella Immunopharma (NASDAQ:ESLA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Estrella Immunopharma (ESLA) operate in?

Estrella Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Estrella Immunopharma Stock (NASDAQ: ESLA) stock price, news, charts, stock research, profile.

Open	$1.69
Close	$1.48
Volume / Avg.	648.36K / 44.48K
Day Range	$1.42 - $1.78
52 Wk Range	0.63 - 3.23
Market Cap	$52.46M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	0.1%
Days to Cover	1.5

Recent News

This aTyr Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market trading Here are some other stocks moving in pre-market trading.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.69
Close	$1.48
Volume / Avg.	648.36K / 44.48K
Day Range	$1.42 - $1.78
52 Wk Range	0.63 - 3.23
Market Cap	$52.46M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	0.1%
Days to Cover	1.5

About Estrella Immunopharma Inc

Sector

Health Care

Industry

Biotechnology

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-tar...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Estrella Immunopharma (ESLA) stock?

You can purchase shares of Estrella Immunopharma (NASDAQ:ESLA) through any online brokerage.

View our list of the best stock brokerages

Who are Estrella Immunopharma (ESLA) competitors?

Other companies in Estrella Immunopharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Serina Therapeutics (AMEX:SER), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Immuneering (NASDAQ:IMRX).

What is the forecast, or price target, for Estrella Immunopharma (ESLA) stock?

Estrella Immunopharma has a consensus price target of $16.00.

What is the current price for Estrella Immunopharma (ESLA)?

The stock price for Estrella Immunopharma (NASDAQ: ESLA) is $1.45 last updated February 21, 2025 at 4:41 PM EST.

Does Estrella Immunopharma (ESLA) pay a dividend?

There are no upcoming dividends for Estrella Immunopharma.

When is Estrella Immunopharma (NASDAQ:ESLA) reporting earnings?

Estrella Immunopharma’s Q3 earnings are confirmed for Wednesday, May 14, 2025.

Is Estrella Immunopharma (ESLA) going to split?

There is no upcoming split for Estrella Immunopharma.

What sector and industry does Estrella Immunopharma (ESLA) operate in?

Estrella Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Estrella Immunopharma

Estrella Immunopharma (ESLA) Forecast